# Ketryx

> Ketryx is a Cambridge- and Vienna-based enterprise SaaS company that connects regulated product development to the tools engineers already use. Its platform overlays Jira, GitHub, CI/CD and other systems to create live traceability, enforce quality procedures, manage risk and SBOMs, and generate audit-ready documentation. The bet is that compliance should be a byproduct of building, not a separate copy-and-paste ritual at the end.

- **Founded:** 2021
- **Headquarters:** Cambridge, United States
- **Founders:** Erez Kaminski (Co-founder & CEO), Jan Pöschko (Co-founder & CTO)
- **Team size:** Approximately 150 employees in supplied company intelligence; public databases vary
- **Products:** Ketryx Platform, Traceability and automated documentation, Risk, SBOM and cybersecurity management, Validated AI Agents, Professional services
- **Notable:** Raised $39 million in a 2025 Series B led by Transformation Capital, taking total funding above $55 million., Reported in 2026 that four of the top five global medical-device manufacturers use Ketryx., Reported that products built on the platform reach more than 100 million patients worldwide in 2026.

## Products & services

- **Ketryx Platform** — A connected lifecycle and compliance layer that links requirements, risks, code, tests, releases and quality records across existing engineering systems.
- **Traceability and automated documentation** — Continuously builds trace matrices and submission-ready design and development files from work performed in Jira, Git and CI/CD tools.
- **Risk, SBOM and cybersecurity management** — Tracks ISO 14971 risk controls, software components, vulnerabilities and release evidence across the software supply chain.
- **Validated AI Agents** — Human-in-the-loop agents for compliance review, suggested links, artifact generation, change-impact assessment and gap detection in regulated workflows.
- **Professional services** — Regulatory, quality and AI-transformation expertise for implementation, process redesign and regulated product development.

## Achievements

- Raised $39 million in a 2025 Series B led by Transformation Capital, taking total funding above $55 million.
- Reported in 2026 that four of the top five global medical-device manufacturers use Ketryx.
- Reported that products built on the platform reach more than 100 million patients worldwide in 2026.
- Certified by UL Solutions to IEC 62304, ISO 13485 and ISO 14971, effective November 2023.
- Achieved ISO/IEC 27001:2022 certification in May 2026 and maintains SOC 2 Type 2 controls.
- Customer case studies report 90% complexity reduction at HeartFlow, a 50% release-cycle reduction at Beacon Biosignals and a 90-day regulated QMS deployment at Flo Health.

## Latest updates

- **2026-08** — Ketryx announced that Accenture selected its platform as the continuous compliance layer for medtech transformation work.
- **2026-06** — Former Medtronic CEO Bill Hawkins joined Ketryx's board after investing in the company.
- **2026-05** — Ketryx became certified to ISO/IEC 27001:2022.
- **2026-02** — Ketryx highlighted expanded AI-assisted compliance workflows and customer reach above 100 million patients.
- **2025-09** — The company raised a $39 million Series B led by Transformation Capital to expand globally and deepen its AI product roadmap.

## Links

- Website: https://www.ketryx.com/
- LinkedIn: https://www.linkedin.com/company/ketryx/
- Twitter/X: https://twitter.com/KetryxHQ
- YouTube: https://www.youtube.com/@Ketryx

---

Profile page: https://yespress.io/ketryx
Published by YesPress — https://yespress.io
Last updated: 2026-08-22